Daily Routine is a pioneering digitally native probiotics brand that prides itself on being the first lifestyle pharmaceutical in its niche, as emphasized by its slogan, "Routine is the first lifestyle pharmaceutical digitally native probiotics brand." Founded in 2020 and headquartered in the United States, the company is disrupting the probiotics industry by offering high-quality, uniquely formulated clean label probiotics with clinically proven benefits. Its vision to Live Better, Be Better is not just a tagline but a testament to its commitment to its customers' well-being and environmental sustainability. Daily Routine's mission revolves around providing solutions to improve bodily functions and collective impact, all the while ensuring a supply chain with the lowest environmental footprint possible. Despite no public information on its last investment, Daily Routine's innovative approach and alignment with consumer health and sustainability trends make it a potential contender for investors seeking opportunities in the wellness and pharmaceutical space.
There is no investment information
No recent news or press coverage available for Daily Routine.